The Nukleofektion brand, founded in 2001 (Germany), from 167 sister brands and 2617 competing brands. Nukleofektion is a brand of LONZA GRP, listed on the stock exchange of Zurich. The International Securities Identification Number (ISIN) of LONZA GRP is CH0013841017. The sector of Nukleofektion is Medical Diagnostics & Research.
Investment simulator :
Portfolio valuation
LONZA GRP
(Nukleofektion)
over 5 years*
CHF 828.16